
|
Have you had your daily dose today?

|
+ANS+LUPIE+EDITION+BLOG.jpg)
Dysautonomia is a general term used to describe a breakdown, or failure of the autonomic nervous system. The autonomic nervous system controls much of your involuntary functions. Symptoms are wide ranging and can include problems with the regulation of heart rate, blood pressure, body temperature and perspiration. Other symptoms include fatigue, lightheadedness, feeling faint or passing out (syncope), weakness and cognitive impairment.
Autonomic dysfunction can occur as a secondary condition of another disease process, like diabetes, or as a primary disorder where the autonomic nervous system is the only system impacted. These conditions are often misdiagnosed.
Now that you have a definition, here are the objectives of our game! Select your character (I'm always Yoshi so hands off!-- Dibs on
him!) And we can get the game rolling! Basically you are playing on a giant board game, the path navigates you around the Autonomic Nervous System, and your goal is to help regulate the dysfunctional aspects of the ANS! Each player rolls a dice, moves the appropriate number of spaces and then after each player gets a turn, its time for (drum roll please) Battle mini games, and a chance to win coins so that you can buy your sodium filled and electrolyte packed beverages as well as your prescriptions so you can control the dysautonomia best you can and win the game!) After 20 turns, the winner of the game will be the player that has not only the most coins but the most powerade beverages (sodium filled drinks increase blood volume which helps prevent hypotension which is why most people with dysautonomia have a syncopy (or fainting spells!) But if you get low on coins and cannot save up enough to buy your sodium packed beverages and medications, you will experience a laundry list of dysautonomic symptoms that include:

The autonomic nervous system controls the “unconscious” bodily functions, such as heart rate, digestion, and breathing patterns. It consists of two parts: the sympathetic system and the parasympathetic system. The sympathetic system can best be thought of as controlling the “fight or flight” reactions of the body, producing the rapid heart rates, increased breathing, and increased blood flow to the muscles that are to escape danger or cope with stress. The parasympathetic system controls the “quiet” body functions, such as the digestive system. So: the sympathetic system gets us ready for action, while the parasympathetic system gets us ready for rest. Normally, the parasympathetic and sympathetic components of the autonomic nervous systems are in perfect balance, from moment to moment, depending on the body’s instantaneous needs.
In people suffering from dysautonomia, the autonomic nervous system loses that balance, and at various times
the parasympathetic or sympathetic systems inappropriately predominate. Symptoms can include frequent vague but disturbing aches and pains, faintness (or even actual fainting spells), fatigue and inertia, severe anxiety attacks, tachycardia, hypotension, poor exercise tolerance, gastrointestinal symptoms such as irritable bowel syndrome, sweating, dizziness, blurred vision, numbness and tingling, and -- quite understandably -- anxiety and depression.
So if you'd like to try your hand to avoid this, I suggest you do your best and put your best foot forward in our
mini games to win those coins! But beware because the evil Bowser can cast an "episode" of these symptoms upon you at any time! That's right! Even when it is being well controlled, BAM! out of nowhere!-- A slew of symptoms can attack! Are you ready to play?
Mini games that you'll get a chance to try your luck at include (but are not limited to...)
Raking in the sodium!- each player controls their own crane type rake, and the goal is to rake in as many sodium tablets as you can! The gold ones are worth 5x as much and will give that blood volume a good boost to help that hypotensive state!
ANS Control switcheroo!- This game puts one player against the other three, as the one that is flying solo is in charge of the switch that controls the balance between the ANS two components- the parasympathetic and the sympathetic nervous system! His goal is to get the other three plays to become unbalanced and cause an episode of symptoms, while the other three players must work hard to stay up and keep their ANS functioning as normal as possible!

Try your luck- chance boxes!- That's right! Your a contestant on Toad's Chance box so come on down! Take
your chance- you have 5 tries to land on a Gold heart that will control your ANS for 5 turns during the game, an item any player with dysautonomia would be envious of! If you do not win the gold heart, you can still walk away with an item that could help you down the road, such as a powerade, or a blood pressure cuff, and compression stockings to help when your blood pressure dips!
These are just a few of the many mini games we have for you to test your luck at, and should I say gaming skills! So be sure to stop by your local gaming joint and pick up your limited edition copy of Mario Party ANS-limited edition!
Jolt-of-Java: "By desiring little, a poor man makes himself rich"- Democrtitus







#2 Possibility: B-Cell ignores signal from T-Suppressor cell to stop making antibodies

#3 Possibility: Line is scrambled thus stop signal does not get through
In A Lupus Flare
The uncontrolled antibodies in the lupus patient attack the connective tissue of the body.
This results in:
Be sure to check out the Lupus Society of Alberta's page- I stumbled across it during some research and loved it so much I wanted to share it with all of you! Check out the animated flash version of it as well - where they go into further detail and break down each component/player that plays a role in the immune system and lupus and thanks to our friends a the Lupus Society of Alberta for a great resource!
LFA-FLARE Definition Will Make Significant Contribution to Lupus Clinical Research
(Washington, DC) The Lupus Foundation of America (LFA) spearheaded a four-year worldwide initiative with more than 120 lupus experts from 11 countries, the pharmaceutical and biotechnology industries, and federal agencies, which resulted in the first-ever global definition of a lupus flare. The development ofLupus Foundation of America Flare Definition (LFA-Flare) helps to overcome long-standing barriers to the development of new, safe, and more tolerable treatments for lupus.
For the past 15 years, many trials of new investigational medicines for lupus have failed to show significant benefits for patients. A consistent and meaningful definition for a lupus flare is critical to evaluating the effectiveness of treatment over time. The new definition will enable more precise outcome measures for future studies, such as the number of flares or the time between flares. This will have a positive impact on the quality and scientific basis of clinical trials, which are required by the U.S. Food and Drug Administration (FDA) to demonstrate the effectiveness of any new therapy before it can be approved for general use in patients.
**The consensus definition is: A flare is a measurable increase in disease activity in one or more organ systems involving new or worse clinical signs and symptoms and/or lab measurements. It must be considered clinically significant by the assessor and usually there would be at least consideration of a change or an increase in treatment.**
“This definition addresses several controversial issues about how we look at flares of disease, which may have been interfering with the accuracy of how we evaluate new treatments,” said Joan T. Merrill, M.D., head of the Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, and LFA Medical Director.
A paper describing the definition and the consensus process is now available online and will be published in the March or April issue of the medical journal LUPUS. LFA-FLARE has high face validity and now is ready for validation in clinical studies. The Systemic Lupus International Collaborating Clinics (SLICC), a leading international consortium of lupus doctors, is evaluating this definition as a basis for modified outcome measurements of flare to provide an improved scientific basis for clinical trials.
The LFA thanks the lupus researchers from universities and industry who contributed their expertise to this project. A worldwide effort such as this brings hope to millions of people around the world who are living with lupus that new medicines are on the horizon.
The LFA’s National Research Program, Bringing Down the Barriers®, is dedicated to addressing research issues that have for decades obstructed basic biomedical, clinical, epidemiological, behavioral, and translational lupus research. The LFA’s approach to research is unique because it directs its funding to areas of research where gaps exist in the understanding of lupus, and to promising areas of study in which other public and private organizations have not focused their efforts. Using a three-pronged strategy, the LFA and its national network are committed to advancing the science and medicine of lupus by: directly funding research to close the gaps in lupus research; advocating for expanded investment in research from public and private sources; leading special initiatives; and forging collaborative efforts among stakeholders to address critical issues to advancing the science and medicine of lupus. For more information about the LFA’s National Research Program, visit www.lupus.org/research.